Efforts to “reshore” drug manufacturing and address supply shortages in the U.S. have trickled down to central Virginia, where public and private partners have pledged $2.5 million in seed money for an industry accelerator.
Activation Capital is launching the cluster accelerator focused on advanced pharmaceutical manufacturing and R&D in the central Virginia area that includes Petersburg, Virginia, and Richmond, Virginia.
The initiative is backed by public and private sector organizations involved in the region’s pharmaceutical R&D, manufacturing, employment and supply chain development.
